NORSK-TITANIUM-AS
Following the recent announcement by metal Additive Manufacturing innovator Norsk Titanium AS that it will deliver the world’s first FAA-approved, 3D-printed, structural titanium components to Boeing, Norsk Titanium today announced it has closed on a significant investment from Triangle Holdings LP (“Triangle”), an aerospace investment company owned by funds managed by affiliates of Fortress Investment Group LLC (“Fortress”). Triangle has invested over $1.2 billion in aircraft and aerospace related assets since its formation in 2011. Terms of the investment were not released.
“This strategic investment from Triangle Holdings allows Norsk Titanium to extend our Rapid Plasma Deposition™ capability fully into the commercial aerospace sector and beyond that- and accelerates its revolutionary changes to metal manufacturing process forever,” said Norsk Titanium Chairman of the Board John Andersen, Jr. “The capabilities of Triangle and its affiliates are extraordinary, and the ambition demonstrated by this strategic investment will bring Norsk Titanium’s customers unprecedented application opportunities.”
“Our focus is on the integration of advanced technologies with smart production and Industrial Internet-of-Things, which will bring a unique set of competences to our platform technology,” said Norsk Titanium President & Chief Executive Officer Warren M. Boley, Jr. “The fourth industrial revolution is being designed by corporations and individuals who display great vision and bold execution, and I am immensely proud to add Fortress as a partner on this ambitious journey.”
“Based on a Strategic Cooperation Memorandum, our investment in Norsk Titanium reflects our strategy of investing in game-changing businesses across the aerospace sector,” said Jeremy Barnes, a partner in Triangle. “We look forward to working with Norsk Titanium on proliferating its RPD™ technology.”
In March 2017, Norsk Titanium announced that it will deliver the world’s first FAA-approved, 3D-printed, structural Titanium components to Boeing, and in July 2016 announced a $125M state investment to build the world’s first industrial scale metal additive manufacturing plant in Plattsburgh, New York. The Dreamliner RPD™ components will be on display at the International Paris Airshow, Le Bourget June 19-25, 2017 at Norsk Titanium’s booth in Hall 1, Space H299, along with a full-scale mock-up of the company’s patented MERKE IV™ Rapid Plasma Deposition™ machine that produced the pioneering structural parts.
About Norsk Titanium AS
Norsk Titanium AS is the world’s pioneering supplier of aerospace-grade, additive manufactured, structural titanium components. The company is distinguished in the aviation industry by its patented Rapid Plasma Deposition™ (RPD™) process that transforms titanium wire into complex components suitable for structural and safety-critical applications. The Norsk Titanium research and development team is committed to displacing the inefficient forging and machining processes with a precision wire deposition technology enabling substantial savings for aerospace, defense, and commercial applications. To learn more, please visit www.norsktitanium.com
About Triangle
Triangle is an investment vehicle which focuses on the aerospace sector. Its activities range from equity investments in operating businesses to the ownership of an aircraft leasing company. Its primary platform is Falko, a specialist aircraft operating leasing, asset management and aircraft services company focused on the regional aircraft sector. It is one of the world’s largest managers of regional jets by aircraft numbers. Triangle was formed in July 2011 when funds managed by Fortress Investment Group completed the purchase of BAE Systems Asset Management and its associated aircraft portfolio. For further information visit www.falko.com or follow us on Twitter: Falko_RA
View source version on businesswire.com: http://www.businesswire.com/news/home/20170611005086/en/
Contact:
Griffin Communications Group
George Torres, 310-947-0982
media@norsktitanium.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis2.6.2025 13:00:00 CEST | Press release
ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG. “This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achieve sustained remission with current approved treatment.” About Myasthenia Gravis
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”2.6.2025 13:00:00 CEST | Press release
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts. Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.” As a preferred higher education institution tapped to team up with Lenovo to offer supply chain short-term learning, Bellevue will leverage the breadth and depth of Lenovo’s supply chain expe
Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania2.6.2025 12:30:00 CEST | Press release
Vertically Integrated Plan includes Hydrometallurgical Refinery at Kahama $2.37 Billion After-Tax NPV (8%) and 22.9% After-Tax IRR at $8.49 per Pound Nickel Price Initial Assessment Proposes a 22-Year Mine Plan at Average 2.39% Nickel Equivalent Grade Webcast with Technical Leadership Team at 10 AM ET on Tuesday, June 3, 2025 Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery at Kahama. The study covers the Main, MNB, Kima, North, and Tembo zones and is based on the December 2024 Mineral Resource Update (refer to Lifezone’s December 5, 2024 news
Corpay Cross-Border Named an Official Partner of Real Madrid C.F.2.6.2025 12:00:00 CEST | Press release
Providing access to currency risk management and cross-border payments solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Real Madrid C.F. to become an Official Partner. Through this partnership, Real Madrid will be able to gain access to and utilise Corpay Cross Border’s innovative solutions to help mitigate foreign exchange exposure from their day-to-day business needs. "The Corpay Cross-Border team is elated to be named an Official Partner of Real Madrid, one of the world’s most widely recognized and followed sports franchises," said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “With our strong focus on growing the Corpay brand, as well as our currency risk management business, we are excited to partner with one of the most successful football clubs in the world.” About Corpay Corpay, Inc. (NYSE: CPAY) is a global S&P500 corporate payments co
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 20252.6.2025 12:00:00 CEST | Press release
Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4-targeting ADC and CDK2 inhibitorData underscore strength of emerging breast cancer pipeline as part of BeOne’s global transformation with next wave of innovation BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure. “Presenting the first clinical data for two novel breast cancer candidates at ASCO 2025 marks a pivotal moment for BeOne,” said Mark Lanas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom